144 related articles for article (PubMed ID: 8851650)
1. Effectiveness of venlafaxine treatment in a broad spectrum of depressed patients: a meta-analysis.
Entsuah AR; Rudolph RL; Chitra R
Psychopharmacol Bull; 1995; 31(4):759-66. PubMed ID: 8851650
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, placebo-controlled evaluation of the effects of orally administered venlafaxine on sleep in inpatients with major depression.
Luthringer R; Toussaint M; Schaltenbrand N; Bailey P; Danjou PH; Hackett D; Guichoux JY; Macher JP
Psychopharmacol Bull; 1996; 32(4):637-46. PubMed ID: 8993085
[TBL] [Abstract][Full Text] [Related]
3. A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients.
Nemeroff CB; Thase ME;
J Psychiatr Res; 2007; 41(3-4):351-9. PubMed ID: 16165158
[TBL] [Abstract][Full Text] [Related]
4. Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
Hewett K; Chrzanowski W; Schmitz M; Savela A; Milanova V; Gee M; Krishen A; Millen L; Leary MO; Modell J
J Psychopharmacol; 2009 Jul; 23(5):531-8. PubMed ID: 18635695
[TBL] [Abstract][Full Text] [Related]
5. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
Malhi GS; Ng F; Berk M
Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
[TBL] [Abstract][Full Text] [Related]
6. Low frequency (1-Hz), right prefrontal repetitive transcranial magnetic stimulation (rTMS) compared with venlafaxine ER in the treatment of resistant depression: a double-blind, single-centre, randomized study.
Bares M; Kopecek M; Novak T; Stopkova P; Sos P; Kozeny J; Brunovsky M; Höschl C
J Affect Disord; 2009 Nov; 118(1-3):94-100. PubMed ID: 19249105
[TBL] [Abstract][Full Text] [Related]
7. Extended-release venlafaxine in relapse prevention for patients with major depressive disorder.
Simon JS; Aguiar LM; Kunz NR; Lei D
J Psychiatr Res; 2004; 38(3):249-57. PubMed ID: 15003430
[TBL] [Abstract][Full Text] [Related]
8. Comparison of short-term venlafaxine versus lithium monotherapy for bipolar II major depressive episode: a randomized open-label study.
Amsterdam JD; Shults J
J Clin Psychopharmacol; 2008 Apr; 28(2):171-81. PubMed ID: 18344727
[TBL] [Abstract][Full Text] [Related]
9. Venlafaxine versus nortriptyline in the treatment of elderly depressed inpatients: a randomised, double-blind, controlled trial.
Kok RM; Nolen WA; Heeren TJ
Int J Geriatr Psychiatry; 2007 Dec; 22(12):1247-54. PubMed ID: 17562523
[TBL] [Abstract][Full Text] [Related]
10. Venlafaxine for panic disorder: results from a double-blind, placebo-controlled study.
Pollack MH; Worthington JJ; Otto MW; Maki KM; Smoller JW; Manfro GG; Rudolph R; Rosenbaum JF
Psychopharmacol Bull; 1996; 32(4):667-70. PubMed ID: 8993089
[TBL] [Abstract][Full Text] [Related]
11. Venlafaxine for treatment-resistant unipolar depression.
Nierenberg AA; Feighner JP; Rudolph R; Cole JO; Sullivan J
J Clin Psychopharmacol; 1994 Dec; 14(6):419-23. PubMed ID: 7884023
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of high dose of venlafaxine XL in treatment resistant major depression.
Mbaya P
Hum Psychopharmacol; 2002 Oct; 17(7):335-9. PubMed ID: 12415551
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
[TBL] [Abstract][Full Text] [Related]
14. Subchronic antidepressant treatment with venlafaxine or imipramine and effects on blood pressure and heart rate: assessment by automatic 24-hour monitoring.
Gründer G; Wetzel H; Schlösser R; Benkert O
Pharmacopsychiatry; 1996 Mar; 29(2):72-8. PubMed ID: 8741025
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and safety of venlafaxine extended release in elderly depressed patients.
Ibor JJ; Carrasco JL; Prieto R; García-Calvo C;
Arch Gerontol Geriatr; 2008; 46(3):317-26. PubMed ID: 17617478
[TBL] [Abstract][Full Text] [Related]
16. Nefazodone in the treatment of severe, melancholic, and recurrent depression.
Marcus RN; Mendels J
J Clin Psychiatry; 1996; 57 Suppl 2():19-23. PubMed ID: 8626359
[TBL] [Abstract][Full Text] [Related]
17. A randomised study comparing escitalopram with venlafaxine XR in primary care patients with major depressive disorder.
Montgomery SA; Huusom AK; Bothmer J
Neuropsychobiology; 2004; 50(1):57-64. PubMed ID: 15179022
[TBL] [Abstract][Full Text] [Related]
18. Venlafaxine in depressed outpatients.
Khan A; Fabre LF; Rudolph R
Psychopharmacol Bull; 1991; 27(2):141-4. PubMed ID: 1924660
[TBL] [Abstract][Full Text] [Related]
19. Long-term safety and clinical acceptability of venlafaxine and imipramine in outpatients with major depression.
Shrivastava RK; Cohn C; Crowder J; Davidson J; Dunner D; Feighner J; Kiev A; Patrick R
J Clin Psychopharmacol; 1994 Oct; 14(5):322-9. PubMed ID: 7806687
[TBL] [Abstract][Full Text] [Related]
20. Depression in primary care: effectiveness of venlafaxine extended-release in elderly patients; Observational study.
Cervera-Enguix S; Baca-Baldomero E; Garcia-Calvo C; Prieto-López R;
Arch Gerontol Geriatr; 2004; 38(3):271-80. PubMed ID: 15066313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]